- HSP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $53.9 million.
- HSP is up 2.8% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in HSP with the Ticky from Trade-Ideas. See the FREE profile for HSP NOW at Trade-Ideas More details on HSP: Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies to develop, manufacture, distribute, and market products worldwide. The company operates through Americas, EMEA, and APAC segments. HSP has a PE ratio of 30.4. Currently there is 1 analyst that rates Hospira a buy, no analysts rate it a sell, and 10 rate it a hold. The average volume for Hospira has been 915,700 shares per day over the past 30 days. Hospira has a market cap of $10.0 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.01 and a short float of 3.7% with 6.12 days to cover. Shares are up 45.6% year-to-date as of the close of trading on Friday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.